Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres

被引:15
作者
Boanini, Elisa [1 ]
Panseri, Silvia [2 ]
Arroyo, Fabiola [3 ]
Montesi, Monica [2 ]
Rubini, Katia [1 ]
Tampieri, Anna [2 ]
Covarrubias, Cristian [3 ]
Bigi, Adriana [1 ]
机构
[1] Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy
[2] Natl Res Council Italy, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Italy
[3] Univ Chile, Inst Res Dent Sci, Fac Dent, Lab Nanobiomat, Santiago 8380492, Chile
关键词
mesoporous; bioactive glass nanospheres; alendronate; osteoclast inhibition; anti-cancer; OSTEOCLAST DIFFERENTIATION; BISPHOSPHONATE THERAPY; OSTEOSARCOMA CELLS; BONE-RESORPTION; DRUG-DELIVERY; CANCER-CELLS; HYDROXYAPATITE; ZOLEDRONATE; EXPRESSION; RELEASE;
D O I
10.3390/ma9030135
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In this work we synthesized mesoporous bioactive glass nanospheres (nMBG) with the aim to utilize them as substrates for loading one of the most potent amino-bisphosphonates, alendronate (AL). The results of the chemical and structural characterization show that the nMBG display a relatively high surface area (528 m(2)/g) and a mean pore volume of 0.63 cm(3)/g, both of which decrease on increasing alendronate content. It is possible to modulate the amount of AL loaded into the nanospheres up to a maximum value of about 17 wt %. In vitro tests were performed using a human osteosarcoma cell line (MG63) and a murine monocyte/macrophage cell line as osteoclast model (RAW 264.7). The results indicate that even the lower concentration of alendronate provokes decreased tumor cell viability, and that osteoclast activity exhibits an alendronate dose-dependent inhibition. The data suggest that nMBG can act as a suitable support for the local delivery of alendronate, and that the antiresorptive and antitumor properties of the functionalized mesoporous nanospheres can be modulated by varying the amount of alendronate loading.
引用
收藏
页数:12
相关论文
共 46 条
[1]   Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway [J].
Akiyama, Toru ;
Dass, Crispin R. ;
Choong, Peter F. M. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) :3461-3469
[2]   Increased osteoclast activity is associated with aggressiveness of osteosarcoma [J].
Avnet, Sofia ;
Longhi, Alessandra ;
Salerno, Manuela ;
Halleen, Jussi M. ;
Perut, Francesca ;
Granchi, Donatella ;
Ferrari, Stefano ;
Bertoni, Franco ;
Giuti, Armando ;
Baldini, Nicola .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (06) :1231-1238
[3]   Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials [J].
Balas, Francisco ;
Manzano, Miguel ;
Horcajada, Patricia ;
Vallet-Regi, Maria .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (25) :8116-8117
[4]   Nanocrystalline hydroxyapatite coatings on titanium: a new fast biomimetic method [J].
Bigi, A ;
Boanini, E ;
Bracci, B ;
Facchini, A ;
Panzavolta, S ;
Segatti, F ;
Sturba, L .
BIOMATERIALS, 2005, 26 (19) :4085-4089
[5]   Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses [J].
Boanini, Elisa ;
Torricelli, Paola ;
Gazzano, Massimo ;
Della Bella, Elena ;
Fini, Milena ;
Bigi, Adriana .
BIOMATERIALS, 2014, 35 (21) :5619-5626
[6]   Crystalline Calcium Alendronate Obtained by Octacalcium Phosphate Digestion: A New Chance for Local Treatment of Bone Loss Diseases? [J].
Boanini, Elisa ;
Torricelli, Paola ;
Gazzano, Massimo ;
Fini, Milena ;
Bigi, Adriana .
ADVANCED MATERIALS, 2013, 25 (33) :4605-4611
[7]   The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro [J].
Boanini, Elisa ;
Torricelli, Paola ;
Gazzano, Massimo ;
Fini, Milena ;
Bigi, Adriana .
BIOMATERIALS, 2012, 33 (02) :722-730
[8]   Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines [J].
Cheng, YY ;
Huang, L ;
Lee, KM ;
Li, K ;
Kumta, SM .
PEDIATRIC BLOOD & CANCER, 2004, 42 (05) :410-415
[9]  
Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153
[10]   Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review [J].
Eriksen, Erik F. ;
Diez-Perez, Adolfo ;
Boonen, Steven .
BONE, 2014, 58 :126-135